Dr. Michael Joseph Bolesta is a Dallas, Texas based male orthopedic surgeon who is specialized in Orthopaedic Surgery of the Spine. Active license number of Dr. Michael Joseph Bolesta is J5702 for Orthopaedic Surgery of the Spine in Texas.
Dr. Michael Joseph Bolesta deals with the evaluation and nonoperative and operative treatment of the full spectrum of primary spinal disorders including trauma, degenerative, deformity, tumor, and reconstructive.
Complete Profile:
Dr. Michael Joseph Bolesta speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Orthopedic - Orthopaedic Surgery of the Spine
Credentials:
MD
Gender:
Male
Practice Address:
5323 Harry Hines Blvd, Dallas, Texas, 75390-7208
Phone:
214-645-0624
Fax:
214-645-0078
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1205896149
NPI Enumeration Date:
24 Mar, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Michael Joseph Bolesta are as mentioned below.
License Number
Specialization
State
Status
J5702
Orthopaedic Surgery of the Spine
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 845347, Dallas, Texas
Zip:
75284-5347
Phone Number:
214-645-0624
Fax Number:
214-645-0078
Patients can reach Dr. Michael Joseph Bolesta at 5323 Harry Hines Blvd, Dallas, Texas or can call to book an appointment on 214-645-0624. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.